KALYNN JOLLY: Open Payments
NPI 1386276715 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 15 payments from 6 companies in 2025. Trend: 2023 $19 · 2024 $134 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $134 |
| Amgen Inc. | 3 | $49 |
| ABBVIE INC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
Products named: Wegovy, VRAYLAR, Rybelsus, OTEZLA, Kerendia, Leqembi, REPATHA, FREESTYLE LIBRE 3.
Industry payments across IN — which companies pay providers there.
